Annals of the New York Academy of Sciences 1993: Vol 683 Index

9 Pages·1993·0.89 MB·English

Subject Index
.Abdominal adiposity and insulin resistance. C^alorimeter, indirect, 142
111-112 Carbohydrate conversion into fat, 124
Acetyl CoA carboxylase activity in liver, 186 Carbohydrate oxidation, 126
Acipimox Carbohydrate-to-fat ratios, 136
and cholesterol in liver, 190 Carbohydrates
and fish oil, 183-190 dietary, effects of, 57-67
Adipocyte glucose transporter, skeletal dietary fats, and weight, 122-137
muscle, and heart, 94 Cardiovascular disease
Adiptocyte insulin binding and diet, 152-153 and diabetes, 112-113
Adipocyte insulin resistance, fish oil and lard and insulin action, 110-111
diet in, 98-100 obesity and diabetes in, 344
Adif>ocyte plasma membrane composition Cardiovascular risk, diet and, 192
and diet, 151-152 Catecholamines in hypertriglyceridemia, 283,
Adipocytes 284,287
glucose transport in, after fish oil, 238-239 Cell cultures and lipid modification, 164-166
impaired insulin-stimulated glucose Cerebrovascular disease in Greenland and
uptake in, 92 Denmark, 9
Aerobic exercise, effects of, 132-133 Chinese hamster ovary cell line and LDL
Aging and B-cell function, 233-235 binding, 178-179
Alcohol consumption and weight gain, 147 Cholesterol blood levels and high fat diet,
American Diabetes Association dietary 100
recommendations, 199-200 Chylomicronemia reduced by fish oil, 23
Antihypertensive effect of fish oils, 40-42 Corticosterone, 134
Antioxidants, influence of, on blood Cynomologus monkeys and lipid levels, 180
pressure, 42
Arachidonic acid
and diet, 326-327 Deadly quartet. See Insulin resistance
and streptozotocin diabetes, 365-366 syndrome
Athrogenesis, lipoproteins and, 360-361 Denmark and Greenland, mortality patterns
Atherosclerosis, fish oil in, 376-377 in, 9
Atherosclerotic vascular disease, NIDDM DHA. See Docosahexaenoic acid
and,341-342 Diabetes
Australian Aborigines, diet of, 326-327 abnormal serum fatty acid composition
and,367-370
adult-onset, and fish oil, 337-340
Behavioral factors in weight gain, 147 and cardiovascular disease, 325
Beta-adrenergic receptors, 282, 284, 287 and dietary fatty acids, 159
Binding, insulin, and nuclear envelope, dietary n-3 fatty acids in, 244-248
157-159 docosahexaenoic acid emulsion in,
Blood pressure 207-211
and fish oil in hypertriglyceridemia, erythrocyte and platelet fluidity in,
353-355 371-372
and omega-3 fatty acids, 35-42 fatty acids and hypertension in, 331-333
glucoregulation, and triglyceridemia, fish oil, and insulin action in fat cells, 213
57-67 fish oil in, 341-342
influence of antioxidants on, 42 fish oils and insulin action in, 250-257
low salt diet and, 289-294 hypertriglyceridemia in patients with, 85
Body composition in Eskimos, 9-10
and fuel oxidation, 127 insulin action in, 258-268
and weight maintenance, 129-132 insulin resistance and, 193
Body weight metabolic effects of n-3 fatty acids in,
food consumption and, 185-186 272-278
gain, risk factors for, 143-144 monounsaturated fatty acids and, 199-205
maintenance, 136 non-insulin dependent, in San Luis Valley,
regulation, 122 46-56
381
382 ANNALS NEW YORK ACADEMY OF SCIENCES
pKjstprandial triglycerides after lipid load Familial disorder, obesity as, 141-142
in, 315-320 Fat
n-6/n-3 ratio in, 258-268 and diabetes, 259-261
streptozotocin carbohydrates, and weight, 122-137
and archidonic acid, 365-366 dietary impact of, 132
muscle protein levels in, 218-225 fish, and blood pressure, 35-42
type 2, and omega-3 fatty acids, 114 oxidation of, 124, 145
with hypertriglyceridemia, 300 subtypes, and insulin action, 107
Diabetic adipocytes and glucose transjjort, Fat balance vs energy balance, 148
153-155 Fat cells, insluin action in, with fish oil,
Diet 213-216
and insulin responsiveness, 151-162 Fat-modified vs low fat diets, metabolic
and nuclear envelope, 157-159 effects of, 192-196
diabetes and, 199-205 Fatty acid changes in triglyceride and
fat-modihed, glucose and lipid metabolism glucose, 351-352
in, 279-280 Fatty acid composition of membrane
fat-modified vs low fat, 192-196 phospholipids, 86
n-3 fatty acids in, 69-79 Fatty acid oxidation, inhibition of, in
and diabetes, 244-248 perfused liver, 357-359
high carbohydrate vs high fat, 102 Fatty acid synthetase and high fat diet, 99,
high fat 100
and body weight and adipose tissue Fatty acid utilization in muscle after fructose
weight, 99 feeding, 60
in insulin resistance, 84 Fatty acids. See also Omega-3 fatty acids
in streptozotocin-treated rats, 228-236
and hypertension in diabetes, 331-333
high sucrose, glucose transport in
and insulin resistance, 69-79
adipocytes on, 237-243
and LDL binding, 178-181
insulin resistance induced by, 82-88
erythrocyte and platelet fluidity effects in,
low salt, in hypertriglyceridemia, 289-294
371
Dietary recommendations in diabetes,
from fish oil, 16-34
343-345
high, glucose tolerance and, 279-280
Docosahexaenoic acid emulsion in diabetes,
hypolipidemia and, 378-379
207-211
in diabetes, 272-278
Dyslipidemia
in dietary treatment of metabolic
and increased insulin concentrations, 1-7
disorders, 322-327
in Asian Indians, 265-266
insulin, and sucrose, 346-348
mechanisms of, 6
insulin resistance and, 84
insulin response to, in diabetes, 245
Energy expenditure, components of, kinetics of, in hypertriglyceridemia,
142-143 373-375
Energy intake vs energy expenditure, 141 monounsaturated, in diabetes, 199
Environmental factors and insulin serum, and NIDDM, 367-370
responsiveness, 168 Fiber, vegetable, in diet, 194
Epidemiologic observations on diet, 114 Fish
Epidemiologic studies on Eskimos and fish consumption in Eskimo diet, 10
intake, 9-14 dietary fats, and blood pressure, 35^2
Erythrocyte membrane fluidity, fatty acids intake
and,371-372 and coronary heart disease, 10-11
Eskimos and Eskimos, epidemiologic studies on,
cardiovascular disease in, 9-10 9-14
diabetes in, 9-10 low, biologic effects of, 13
diet of, 10 Fish oil
epidemiologic studies on, and fish intake, and acipimox, 183-190
9-14 and atherosclerosis, 376-377
hemorrhagic stroke in, 11 and blood pressure, 353-355
plasma lipids in, 9-10 and cardiovascular risk in NIDDM,
Exercise, effects of, 132 113-114
SUBJECT INDEX 383
and cholesterol, 189 Glucose tolerance test to assess insulin
and glucose tolerance, 114 action, 106
and hypertension, 37 Glucose transport
and insulin in diabetes, 110-118, 250-257 and insulin action in adifKx^tes, 153-155
and insulin resistance, 91-92 in adipocytes after fish oil, 238-239
and lard diet in obesity, 98-100, 349-350 in streptozotocin-induced diabetes,
and LDL binding, 180-181 218-225
and serum lipids, 113-114 Glucose transporter
anticoronary action of, 16-32 and diet, 94, 99,100
dietary, and insulin action, 110-118 insulin stimulation and, 91-92
fatty acids from, 16-34 protein levels in diabetes, 218-225
glucose uptake in adipocytes and, 237-243 Glucose uptake and insulin resistance. 111
glycemic control and, 114 Glucose utilization, fish oil and, 214
hypolipidemic effects of, 378-379 GLUT. See Glucose transporter
hypotriglyceridemia, and diabetes, Glycemic control and omega-3 fatty acids,
337-340 116
in NIDDM, 341-342 Glycogen reserves, 124
in streptozotocin-induced diabetes, Glycogen, tissue, and triglyceride stores, 93
Greenland and Denmark, mortality patterns
218-225
insulin action in fat cells and, 213-216 in, 9
Food intake regulation and energy
expenditure, 127 High density lipoproteins (HDL) and
Food quotient (FQ), 123 insulin, 5
Food, thermic effect of, 142 Heart, skeletal muscle, and adipocyte
FQ. See Food quotient glucose transporter, 94
Frequent sampling intravenous glucose Hemorrhagic stroke in Eskimos, 11
tolerance test (FSIGT), 296, 374 Hereditary hypertriglyceridemia
Fructose feeding and insulin action, 58 low salt diet in, 289-294
FSIGT. See Frequent sampling intravenous nonobese rat model of, 61
glucose tolerance test High carbohydrate V5 high fat diets, 102
Fuel oxidation and body composition, 127 Hispanics, diabetes among, 46-56
HTG. See Hypertriglyceridemia
Hyperlipemia
Cjlibenclamide in diabetes, 266 and obesity, diet in, 349-350
Glucocorticoid hormones and obesity, 134 fish oil and high lard diet in, 98-100
Glucoregulation, triglyceridemia, and blood Hypertension and fatty acids in diabetes,
pressure, 57^7 331-333
Glucose Hypertriglyceridemia, 111
and insulin stimulation in obese subjects, blood pressure and fish oil, 353-355
173,174 fatty acid changes in, 351-352
n-3 fatty acids and, 252 fish oil and, 16-34
high fat diet and, 100 insulin action in, 295-300
in diabetes, 337-340 insulin resistance in, 281-287
in hypertriglyceridemia, 295-300 kinetics of free fatty acids in, 373-375
Glucose metabolism low salt diet in, 289-294
and NIDDM, 193 Hypolipidemic effect of fish oil, 183-190
in fat-modified diet, 279-280 Hypotriglyceridemia, fish oil, and diabetes,
in hypertriglyceridemia, 351-352 337-340
Glucose regulation after high fructose
intake, 58 IdDM. See Diabetes
Glucose, serum, and insulin in diabetes, Indian (Asian) diet, 261-263
207-211 Insulin
Glucose tolerance concentrations and serum glucose in
and dietary lipids, 46-56 diabetes, 207-211
and fish oil, 114,378-379 effect on glucose transport in adipocytes,
and insulin, 92,112-113 240-241,242
in streptozotocin-treated rats, 228-236 fatty acids, and sucrose, 346-348
384 ANNALS NEW YORK ACADEMY OF SCIENCES
glucose tolerance and, in fat-modified diet, Ischemic heart disease in Greenland and
279-280 Denmark, 9
Insulin action
after high fructose intake, 59 Lard and fish oil diet in obesity, 98-100,
after high sucrose intake, 59 349-350
and high-fat diet, 100 LDL and insulin, 4-5
and 24-hour glycemia, 344 LDL binding and dietary fatty acids, 178-181
and liptoprotein concentrations, 1-3 LDL receptor and cholesterol in liver, 188
and VLDL, 4 Linoleic acid and insulin binding, 166
dietary fish oil and, 110-118, 213-216, Lipid load, oral, triglycerides and
250-257 lipKrproteins after, 315-320
dietary lipids and, 102-108 Lipid modulation of tyrosine kinase activity,
fatty acids, and hypertriglyceridemia, 351 164-170
glucose tolerance and, 112-113 Lipids
impaired, and fatty acid flux. 111 and glucose tolerance, 46-56
and free fatty acids, 5 basal and prandial, in NIDDM, 344
and HDL, 5 dietary, and insulin action, 102-108,
and VLDL, 5 151-162
lipid oxidation and, 254-256 and insulin secretion, 172-177
omega-3 fatty acids and, 116 in Eskimos, 9-10
Insulin binding structural order parameters of, 173-174,
adipocyte, and diet, 152-153 175
and altered lipid composition of cells, 165 Lipogenesis, 124
in adipocytes and diet, 152 Lipioproteins
in spontaneously diabetic rat, 159-160 concentrations and insulin, 1-3
Insulin receptor signaling and lipid effects of fish oil on, 16-34
environment, 167 diabetes after lipid load, 315-320
Insulin receptor tyrosine kinase activity, lipase and insulin resistance, 111
164-170 oxidation of, 363-364
Insulin resistance Liver
after high fat-fed rats, 91-96 glycogen concentrations and diet, 93
and lipoprotein abnormalities, 6 inhibition of fatty acid oxidation in,
and secretion in hypertriglyceridemia, 357-359
295-300 malic enzyme activity, and
and starvation, 168 triiodothyronine, 360-361
early study by Himsworth, 106 Low salt diet in hypertriglyceridemia,
fish oil and high lard diet in, 98-100 289-294
high fat diet-induced, 82-88
in hypertriglyceridemic rats, 281-287 Malic enzyme activity and
sucrose-induced, 69-79 triiodothyronine, 360-361
typtes of, 373-375 Membrane composition
Insulin resistance syndrome, etiology of, 1 and diet, 152
Insulin response and fluidity, 94-96
after neonatal streptozotocin in rats, Membrane lipids
232-235 and insulin action, 91
in muscle, 155-157 and insulin receptor signaling, 167
to fish oil in diabetes, 277 3-Mercaptopropionic acid to inhibit fatty
to n-3 fatty acids in diabetes, 244-245 acid oxidation, 357-359
Insulin secretion Metabolic effects
and dietary lipids, 172-177 of high fat diets, 100
and fish oil, 378-379 of insulin resistance, 111
Insulin sensitivity of omega-3 fatty acids, 116
and glucose tolerance, 92 Metabolic rate and obesity, 144
and weight gain, 146 Metabolic syndrome and triglycerides,
dietary fiber and, 195 302-311
Insulin-dependent diabetes, Metabolism, abnormal, and diet, 195
monounsaturated fat diet in, 203 Middle age
SUBJECT INDEX 385
diet and glucose tolerance in, 12 Oxidative modification of low density
hypertriglyceridemia in, 295-300 lipoproteins, 360-361
Minimal Model to assess insulin action, 106
Monounsaturated fatty acids P
in diabetes, 201 hysical activity, 142-143
sources of, 204 and weight gain, 144
Multiple Risk Factor Intervention Trial, 11 Pima Indians studies, 144
Muscle Plasma lipids in Eskimos, 9-10
GLUT 4 protein levels in diabetes, Plasma lipoproteins and insulin resistance,
218-225 3-4
insulin responsiveness in, 155-157 Platelet aggregation, reduced, in Eskimos, 10
skeletal, heart, and adipocyte glucose Population studies
transporter, 94 diet and blood pressure in, 35-36
skeletal, insulin action on, 85 insulin and lipoproteins in, 2
Postprandial response
to lipid load in diabetes, 315-320
N^-3 fatty acids in healthy subjects, 302-311
from fish oil, 16-32 Prostaglandin F2a and E2 synthesis, 155
in diabetes, 244-248, 272-278 Protein levels of GLUT 4 in diabetes,
in Eskimo diet, 10 218-225
long-term effects of, 13 Protein reconstitution and protein-lipid
N-6 and n-3 fatty acids in metabolic interactions, 166-167
disorders, 322-327 PUFA. See Fatty acids
N-6/n-3 ratio for insulin action in diabetes,
258-268
NIDDM (Non-insulin-dependent diabetes Ra bbits, atherosclerosis in, and fish oil.
mellitus). See also Diabetes 376-377
and insulin resistance, 112-113 Rats
etiology of, 86 hereditary herpertriglyceridemic, 351-352
genetic predisposition in, 86,88 fish oil in, 353-355
lifestyle factors in, 86, 88 low salt diet in, 289-294
Nitrogen balance and body weight, 123 insulin resistance after high fat diet in,
Nuclear envelope and diet, 157-159 91-96
Nutrient intake and oxidation in obesity, 145 spontaneously diabetic, insulin binding in,
Nutritional states, altered, and lipid 159-160
modulation, 167 streptozotocin-treated, high fat feeding in,
232-235
Zucker, obesity and hyperlipemia in,
Obesity 349-350
and diabetes, 344 Respiratory quotient (RQ), 123
and insulin resistance, 108 RQ. See Respiratory quotient
fish oil and high lard diet in, 98-100,
349-350
glycemia and insulin secretion in, 172-177 San Luis Valley Diabetes Study, 46-56
pathogenesis of, 144 insulin and lipoproteins in, 3
risk factors for, 141-148 risk factors in, 47-48
treatment of, 148 Saturated fats
Omega-3 fatty acids and insulin resistance, 92
and blood pressure, 35-42 (0-6 monounsaturates, and trans fatty acids,
and insulin action, 116 36
and insulin secretion, 118 Serum cholesterol and LDL receptor in liver,
and muscle synthesis, 155-156 186-187
blood pressure lowering effect of, 37-42 Serum glucose
effects on glycemic control, 114 and impaired insulin action, 185-186
in fat, 151-152 and insulin response in diabetes, 244-248
in insulin resistance, 84 Serum lipids and fish oil, 113-114
in membrane phospholipid, 86 Seven Countries Study of cardiovascular
Omega-6 fatty acids in insulin resistance, 84 disease, 11
1
t
386 ANNALS NEW YORK ACADEMY OF SCIENCES
Skeletal muscle, heart, and adipocyte glucose and insulin, 4
transporter, 94 and metabolic syndrome, 302-311
Socioeconomic factors in weight gain, 147 and sucrose diet, 186
Sodium intake, dietary, and response to fish high, and skeletal muscle insulin action, 85
oils, 39-40 high fat diet, 100
Starvation and insulin resistance, 168 metabolism in streptozotocin diabetes,
Streptozotocin diabetes 218-225
and arachidonic acid feeding, 365-366 postprandial, and lipids in diabetes,
DHA emulsions in, 207-208 315-320
fish oil effects in, 213 serum, in Wistar rat, 62
muscle GLUT 4 protein levels in, 218 synthesis and n-3 fatty acids, 28-30
Streptozotocin-treated rats, glucose Triiodothyronine and malic enzyme activity,
tolerance in, 228-236 360-361
STZ. See Streptozotocin Type 1 diabetes, fatty acids and hypertension
Sucrose in, 331-333
and acipimox effects on body weight, Tyrosine kinase activity
185-186 and insulin action, 166
and glucose tolerance, 58 in liver, and sucrose, 346-348
and insulin resistance, 69-79,168
insulin, and fatty acids, 346-348 LDL and insulin, 4
Syndrome X. See Insulin resistance
syndrome
Syndromes of insulin resistance, 86 AVeight, dietary fats, and carbohydrates,
122-137
Weight gain, socioeconomic factors in, 147
Tissue glycogen and triglyceride stores, 93
Western Electric Study of diet, 11
Triglyceridemia, glucoregulation, and blood
pressure, 57-67
Triglycerides Zucker rats, obesity and hyperlipemia in,
accumulation in liver, 357-359 349-350
and acetyl CoA carboxylase, 188 Zutphen Study of Dutch diet, 11
Index of Contributors
r\lamowitch, C., 213-217 Hainault, I., 98-101,349-350
Ausieker, S., 315-321 Hajduch, E., 98-101, 349-350
Hamazaki, T., 207-212
Hamman, R. F., 46-56
Bakker, I. M., 228-236
Hannah, J., 178-182
Baracos, V. E., 151-163
Hatcher, L., 337-340
Ba5e. J., 272-278
Heine. R. J., 110-121
Baur, L. A., 82-90
Hermann, M., 183-191,363-364
Beilin, L. J., 35-45
Howard, B. V., xiii, 1-8, 178-182,343-345
Beyer, J., 302-314,315-321
Howard, W. J., 341-342
Biesalski, H. K., 302-314
Hromadova, M., 183-191, 360-362
Bila, V., 57-68
Hubert, P., 164-171, 346-348
Bogardus, C., 141-150
Husek, P., 281-288
Bohov, P., 346-348,360-362,367-370
Boillot, A., 213-217
Brtko, J., 360-362 Jezova, D., 289-294
Bruzzo, F., 213-217
ICrhapaa, P., 279-289
Carlotti, M., 98-101, 349-350 Kasim, S. E., 250-257
Cattaneo, A. G., 172-177 Kataoka, S., 178-182
Caviezel, F., 172-177
Kaul, S., 178-182
Cheema, S., 151-163
Kazdova, L., 57-68,69-81, 272-278,376-377
Chevalier, A., 213-217
Keppler, I., 302-314
Clandinin, M. T., 151-163
Klimes, I., xi, 57-68, 69-81,164-171,
Collier, F. McL., 365-366 183-191,218-227,237-243, 289-294,
Collier, G. R., 322-330,365-366 343-345,346-348,353-356, 360-362,
Connor, S. L., 16-34 367-370
Connor, W. E., 16-34,337-340
Knopp, J., 360-362
Cremel, G., 164-171, 346-348
Kobayashi, M., 207-212
Cerny, L., 351-352 Kohout, M., 272-278
Kovacsova, B., 353-356
DeFrancesco, C. A., 16-34 Kfen, V., 57-68
Dobekrva, Z., 57-68, 281-288 Kriketos, A. D., 82-90
Dvorak, P., 295-301,373-375 Kristek, F., 353-356
Kromhout, D., 9-15
Kruszynska, Y. T., 91-97
Edelsteinova, S., 353-356
Kunes, J., 57-68, 281-288
Kvapil, M., 295-301,373-375
Fenselau, S., 302-314,315-321 KyseloviC, J., 353-356
Ferretti, G., 371-372
Feskens, E. J. M., 9-15
Fickova, M., 164-171, 237-243, 346-348 Xjaakso, M., 279-280
Field, C. J., 151-163 Landgraf, R., 331-336
Flatt, J. P., 122-140 Langer, P., 360-362
Fdldes, O., 289-294 Laue, C, 302-314
Fontvieille, A. M., 141-150 Lavau, M., 98-101,349-350
Fryer, L. G., 91-97 Leray, C, 164-171
Fumelli, P., 371-372 Leray, V., 164-171
Lichardus, B., 289-294
Luo, J., 213-217
Galassi, R., 371-372
Garg, A., 199-206
Gelienova, K., 367-370 Macho, L., 237-243, 346-348
Giansanti, R., 371-372 Makimattila, S., 279-280
Gmeiner, B., 363-364 Makinen, E., 279-280
Guichard, C., 98-101, 349-350 Marshall, J. A., 46-56
388 ANNALS NEW YORK ACADEMY OF SCIENCES
Matejckova, M., 376-377 Sinclair, A. J., 322-330
Mazzanti, L., 371-372 Sindelkova, E., 378-379
Meuillet, E., 164-171 Slama, G., 213-217
Minchenko, A., 183-191 Smith, F. E., 337-340
Mitkova, A., 183-191, 218-227, 237-243, Staedel, C., 164-171, 346-348
289-294,353-356 Stolba, P., 57-68, 218-227, 281-288, 295-301,
Moss, R., 218-227 373-375
Storlien, L. H., xii, 82-90,343-345
N^akamura, N., 207-212 Svabova, E., 346-348
Nakamura, Y., 357-359 Svec, P., 353-356
Nedvi'dek, J., 281-288 Swinburn, B. A., 102-109, 141-150
Nedvi'dkova, J., 281-288
Novakova, V., 376-377
Takazono, I., 357-359
Tutterova, M., 351-352
Opltova, H., 281-288 Tvrzicka, E., 378-379
P
an, D. A., 82-90
Ullmann, D., 337-340
Parillo, M., 192-198
Urbanova, D., 376-377
Pelikanova, T., 272-278
Uusitupa, M., 279-280
Phatak, R. B., 258-271
Pi'safi'kova, A., 378-379
Prellwitz, W., 302-314,315-321 Valek, J., 272-278
Prince, M. J., 337-340 Vavfinkova, H., 351-352
Probst, R., 302-314,315-321 Vessby, B., 244-249
Vidlakova, M., 376-377
Rabini, R. A., 371-372 Vrana, A., 57-68, 69-81,281-288, 289-294,
Radder, J. K., 228-236 351-352, 353-356, 376-377, 378-379
Raheja, B. S., 258-271
Rao, M. B., 258-271
Rasanen, M., 279-289 AVeber, P., 302-314, 315-321
Ravussin, E., 141-150 Wichterle, D., 295-301,373-375
Riccardi, G., 192-198 Wiersma, M. M. L., 218-227, 228-236
Riddle, M., 337-340 Wilson, D., 337-340
Rizkalla, S. W., 213-217
Roques, M., 164-171
Y^amamoto, I., 357-359
Yamamoto, M., 357-359
Sadikot, S. M., 258-271 Yamane, K., 178-182
Schectman, G., 178-182
V
Schrezenmeir, J., 302-314, 315-321
Schwab, U., 279-280 Zak, A., 378-379
Sebdkova, E., 69-81,183-191, 218-227, Zeman, M., 378-379
237-243, 289-294, 343-345, 353-356, Zemankova, A., 289-294
360-362, 367-370 Zuchhold, H. D., 302-314,315-321
\